Obecabtagene autoleucel
Autolus
['leusm']
71 of the patients treated with autolus therapeutics obe-cel in the study (75.5%) experienced cases of cytokine release syndrome (crs), with 3 patients (3.2%) experiencing crs cases that were grade 3 or higher. #asco23 #leusm read more: 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.